Accesibilidad a medicamentos usados para el tratamiento de enfermedades crónicas no transmisibles durante la pandemia por COVID-19, Chiclayo- Perú, 2021
Maritza Mirella Gómez-Pita, Fabrizzio Elky Morales-Zaldívar, H. Arbildo-Vega
{"title":"Accesibilidad a medicamentos usados para el tratamiento de enfermedades crónicas no transmisibles durante la pandemia por COVID-19, Chiclayo- Perú, 2021","authors":"Maritza Mirella Gómez-Pita, Fabrizzio Elky Morales-Zaldívar, H. Arbildo-Vega","doi":"10.37065/rem.v10i2.760","DOIUrl":null,"url":null,"abstract":"Objective: To describe the accessibility of medicines used to treat chronic non-communicable diseases during the COVID-19 pandemic in Chiclayo city. Materials and Methods: The present study was observational, descriptive, cross-sectional and prospective, with a sample of 386 participants, conducted with a questionnaire validated by expert judgment and established reliability through a pilot test. It was structured in two sections, covering sociodemographic, economic and health characteristics of patients with chronic diseases during the COVID-19 pandemic and the four dimensions of accessibility (physical availability, affordability, geographic accessibility and acceptability). Results: 92.5% didn’t had full accessibility to medicines. 45.9%, 53.4%, 83.9% and 23.3% had physical availability, affordability, geographic accessibility and acceptability of medicines, respectively. When accessibility was related to associated factors, it was found that there was a statistically significant relationship (p<0.05) with age, number of people living in thehousehold, monthly income, number of medications and evolution of the disease. Conclusion: The majority of patients treated in health centers and hospitals in Chiclayo did not have full accessibility to their medications during the COVID-19 pandemic, and this was related to the number of people, monthly income, evolution of the disease, age and number of medications.","PeriodicalId":302638,"journal":{"name":"Revista Experiencia en Medicina del Hospital Regional Lambayeque","volume":"64 25","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Experiencia en Medicina del Hospital Regional Lambayeque","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37065/rem.v10i2.760","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To describe the accessibility of medicines used to treat chronic non-communicable diseases during the COVID-19 pandemic in Chiclayo city. Materials and Methods: The present study was observational, descriptive, cross-sectional and prospective, with a sample of 386 participants, conducted with a questionnaire validated by expert judgment and established reliability through a pilot test. It was structured in two sections, covering sociodemographic, economic and health characteristics of patients with chronic diseases during the COVID-19 pandemic and the four dimensions of accessibility (physical availability, affordability, geographic accessibility and acceptability). Results: 92.5% didn’t had full accessibility to medicines. 45.9%, 53.4%, 83.9% and 23.3% had physical availability, affordability, geographic accessibility and acceptability of medicines, respectively. When accessibility was related to associated factors, it was found that there was a statistically significant relationship (p<0.05) with age, number of people living in thehousehold, monthly income, number of medications and evolution of the disease. Conclusion: The majority of patients treated in health centers and hospitals in Chiclayo did not have full accessibility to their medications during the COVID-19 pandemic, and this was related to the number of people, monthly income, evolution of the disease, age and number of medications.